Table: begin end state 1 25 cytoplasmic 26 51 transmembrane 52 60 non-cytoplasmic 61 82 transmembrane 83 93 cytoplasmic 94 113 transmembrane 114 118 non-cytoplasmic 119 140 transmembrane 141 151 cytoplasmic 152 172 transmembrane 173 183 non-cytoplasmic 184 205 transmembrane 206 262 cytoplasmic 263 289 transmembrane 290 302 non-cytoplasmic 303 326 transmembrane 327 335 cytoplasmic 336 356 transmembrane 357 368 non-cytoplasmic 369 394 transmembrane 395 405 cytoplasmic 406 433 transmembrane 434 435 non-cytoplasmic 436 456 transmembrane 457 499 cytoplasmic
Input: >BWI76_RS03110 MSKEQYLTLNKASGPNSETPTTPFVKVVALIATLGGLLFGYDTGVISGALLFMGTELHLT PFTTGLVTSSLLFGAAFGALLSGNLANAAGRKKIILWLAVLFAIGAIGTSMAPDVNWMIF FRLILGVAVGGAAATVPVYIAEIAPANKRGQLVTLQELMIVSGQLLAYISNATFHEVWGG ESTWRWMLAVATLPAVLLWFGMMFMPDSPRWYAMKGRLAEARRVLERTRHKDDVEWELLE ITETLDEQRNLGKPRFSEIMTPWLFKLFMIGIGIAVIQQLTGVNTIMYYAPTVLTSVGMT DNAALFATIANGVVSVLMTFVGIWMLGKIGRRPMTMIGQFGCTACLVFIGAVSYLLPETV NGQPDALRAYMVLAGMLLFLSFQQGALSPVTWLLMSEIFPTRLRGIFMGGAVFSMWIANF LISLFFPILLAWLGLSGTFFIFAGIGVFGAIFVIKCVPETRHRSLEQIEHYLRDKLDTSE EGQAARARRIVAESQANKV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server